Talecris to create 259 jobs

Here's some good biotech job news for a change: Talecris Biotherapeutics, which recently launched a successful IPO, announced that it will create 259 jobs as it plots the $269 million expansion of its manufacturing facility, increasing the 1,800-person workforce it already has in the Research Triangle Park, NC area. The company already added 200 jobs in 2009 and expects the new batch of potions to be filled over the next seven years. Talecris uses plasma to make new therapies for chronic illnesses.

To help facilitate this expansion, the company has been awarded a $250,000 grant from the state's One North Carolina Fund. The developer could also earn up to $4 million in other incentives over the next 12 years if it meets certain criteria.

"The competition for these types of jobs is fierce," said North Carolina Governor Bev Perdue. "The fact that Talecris has found the tools it needs to succeed in North Carolina shows why this state's business climate is consistently named as the best in the nation." Talecris employs 4,700 people worldwide and is a top 10 employer in the Research Triangle Park region.

- see the Governor's release
- here's the report for more

Suggested Articles

Canadian biotech AbCellera has nabbed a meaty $105 million series B funding round as it looks to boost its antibody work and seek out new potential me

Q32 Bio is working on treatments for autoimmune and inflammatory diseases that improve on systemic approaches.

Insitro picked up $143 million to build out its technology, pursue new targets and advance treatments for genetically defined patient groups.